Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Donnelly

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Journal of Craniofacial Surgery|November 28, 2022
Anti PD-1 Checkpoint Inhibitor As a First-Line Treatment for Advanced Cutaneous Squamous Cell CarcinomaKaterina Bopota, Oliver Donnelly, Farzad Borumandi
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|February 5, 2020
Diclofenac Mouthwash as a potential therapy for reducing pain and discomfort in chemo-radiotherapy-induced oral mucositisPeter A Brennan, Rowena Lewthwaite, Poornima Sakthithasan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 25, 2014
Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virusElizabeth Ilett, Timothy Kottke, Oliver Donnelly, et al.
The Journal of Laryngology and Otology|April 2, 2025
Oncological and functional outcomes for transoral robotic surgery versus radiotherapy in T1-2 N0-1 p16+ oropharyngeal carcinomaChang Woo Lee, Wei Jia, Roanna Norman, et al.
Cancers|September 10, 2021
Centralised RECIST Assessment and Clinical Outcomes with Lenvatinib Monotherapy in Recurrent and Metastatic Adenoid Cystic CarcinomaLaura Feeney, Yatin Jain, Matthew Beasley, et al.
Nature Medicine|November 19, 2013
Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrenceTimothy Kottke, Nicolas Boisgerault, Rosa Maria Diaz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2014
The profile of tumor antigens which can be targeted by immunotherapy depends upon the tumor's anatomical siteVanesa Alonso-Camino, Karishma Rajani, Timothy Kottke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 5, 2019
Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase InhibitionVictoria A Jennings, Gina B Scott, Ailsa M S Rose, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|February 15, 2025
Assessment and improvement of the quality of radiotherapy treatment planning CT images using a clinically validated phantom based method and a multicentre intercomparisonAnne T Davis, Andrew Bird, Lorraine Cowley, et al.
Science Translational Medicine|June 16, 2012
Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patientsRobert A Adair, Victoria Roulstone, Karen J Scott, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Craniofacial Surgery|November 28, 2022
Anti PD-1 Checkpoint Inhibitor As a First-Line Treatment for Advanced Cutaneous Squamous Cell CarcinomaKaterina Bopota, Oliver Donnelly, Farzad Borumandi
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|February 5, 2020
Diclofenac Mouthwash as a potential therapy for reducing pain and discomfort in chemo-radiotherapy-induced oral mucositisPeter A Brennan, Rowena Lewthwaite, Poornima Sakthithasan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 25, 2014
Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virusElizabeth Ilett, Timothy Kottke, Oliver Donnelly, et al.
The Journal of Laryngology and Otology|April 2, 2025
Oncological and functional outcomes for transoral robotic surgery versus radiotherapy in T1-2 N0-1 p16+ oropharyngeal carcinomaChang Woo Lee, Wei Jia, Roanna Norman, et al.
Cancers|September 10, 2021
Centralised RECIST Assessment and Clinical Outcomes with Lenvatinib Monotherapy in Recurrent and Metastatic Adenoid Cystic CarcinomaLaura Feeney, Yatin Jain, Matthew Beasley, et al.
Nature Medicine|November 19, 2013
Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrenceTimothy Kottke, Nicolas Boisgerault, Rosa Maria Diaz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2014
The profile of tumor antigens which can be targeted by immunotherapy depends upon the tumor's anatomical siteVanesa Alonso-Camino, Karishma Rajani, Timothy Kottke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 5, 2019
Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase InhibitionVictoria A Jennings, Gina B Scott, Ailsa M S Rose, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|February 15, 2025
Assessment and improvement of the quality of radiotherapy treatment planning CT images using a clinically validated phantom based method and a multicentre intercomparisonAnne T Davis, Andrew Bird, Lorraine Cowley, et al.
Science Translational Medicine|June 16, 2012
Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patientsRobert A Adair, Victoria Roulstone, Karen J Scott, et al.
Pageof 1